RICCARDI, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 816
EU - Europa 559
AS - Asia 299
AF - Africa 24
SA - Sud America 1
Totale 1.699
Nazione #
US - Stati Uniti d'America 808
IT - Italia 418
SG - Singapore 164
CN - Cina 73
VN - Vietnam 40
NL - Olanda 30
CI - Costa d'Avorio 23
DE - Germania 21
IE - Irlanda 16
BE - Belgio 13
FR - Francia 11
GB - Regno Unito 11
FI - Finlandia 10
ES - Italia 9
SE - Svezia 9
CA - Canada 8
HK - Hong Kong 6
IN - India 5
GR - Grecia 4
JP - Giappone 3
CZ - Repubblica Ceca 2
MY - Malesia 2
RO - Romania 2
SY - Repubblica araba siriana 2
BR - Brasile 1
EG - Egitto 1
KR - Corea 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
PK - Pakistan 1
RS - Serbia 1
SI - Slovenia 1
TR - Turchia 1
Totale 1.699
Città #
Chandler 186
Singapore 134
Napoli 96
Naples 78
Ashburn 63
Dong Ket 40
Santa Clara 37
Millbury 36
Beijing 26
Lawrence 25
Des Moines 24
Amsterdam 23
Nanjing 22
Boston 18
Milan 18
Rome 16
Princeton 12
Wilmington 10
Madrid 9
Redwood City 8
Brussels 7
Ottawa 7
Torre del Greco 7
Houston 6
Norwalk 6
Salerno 6
Caserta 5
Fairfield 5
Woodbridge 5
Cinisello Balsamo 4
Forlì 4
Hong Kong 4
Jiaxing 4
Lappeenranta 4
Nanchang 4
Nuremberg 4
Pune 4
Bologna 3
Cava de' Tirreni 3
Esneux 3
Fisciano 3
Guangzhou 3
Kronberg 3
Portici 3
Seattle 3
Shenyang 3
Stockholm 3
Trento 3
Werchter 3
Caivano 2
Cardito 2
Casalbordino 2
Changsha 2
Council Bluffs 2
Dallas 2
Erlangen 2
Florence 2
Fontanarosa 2
Hebei 2
Hung Hom 2
Ipoh 2
Las Vegas 2
Letovice 2
Napa 2
Padula 2
Pozzuoli 2
San Giorgio Del Sannio 2
Stella Cilento 2
Torre Annunziata 2
Trieste 2
Villar Focchiardo 2
Aachen 1
Afragola 1
Avola 1
Belgrade 1
Boardman 1
Bordighera 1
Bruneck 1
Cambridge 1
Capua 1
Cava De' Tirreni 1
Chengdu 1
Cologne 1
Corleto Perticara 1
Dietzenbach 1
Dortmund 1
Ercolano 1
Erice 1
Fremont 1
Giungano 1
Hassan Abdal 1
Iasi 1
Indiana 1
Jinhua 1
La Jolla 1
Leiden 1
Little Rock 1
Ljubljana 1
Marano di Napoli 1
Marigliano 1
Totale 1.076
Nome #
BENZODIFURAN DERIVATIVES AS POTENTIAL ANTIPROLIFERATIVE AGENTS: POSSIBLE CORRELATION BETWEEN THE BIOACTIVITY AND THEIR AGGREGATION PROPERTIES 77
Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action. 76
Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer 67
"dressing up" an Old Drug: An Aminoacyl Lipid for the Functionalization of Ru(III)-Based Anticancer Agents 63
On the pH-Modulated Ru-Based Prodrug Activation Mechanism 59
Ru(III) complexes for anticancer therapy: the importance of being nucleolipidic 58
Synthesis, antiproliferative activity, and DNA binding studies of nucleoamino acid-containing Pt(II) complexes 58
Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity 55
Stability is not everything the case of the cyclization of the thrombin binding aptamer 55
Benzodifurans for biomedical applications: BZ4, a selective anti-proliferative and anti-amyloid lead compound 54
Anticancer activity of a cationic Ru-based nanosystem in a human xenograft model of breast cancer 54
Fluorescence Sensing Using DNA Aptamers in Cancer Research and Clinical Diagnostics 49
G-quadruplex-based aptamers against protein targets in therapy and diagnostics 48
Fighting the Huntington’s Disease with a G-Quadruplex-Forming Aptamer Specifically Binding to Mutant Huntingtin Protein: Biophysical Characterization, In Vitro and In Vivo Studies 47
Insights into the G-rich VEGF-binding aptamer V7t1: when two G-quadruplexes are better than one! 46
A first-in-class and a fished out anticancer platinum compound:: Cis -[PtCl2(NH3)2] and cis -[PtI2(NH3)2] compared for their reactivity towards DNA model systems 44
Preclinical validation of an original Ru(III)-based nanosystem in human models of breast cancer 44
Affinity chromatography-based assays for the screening of potential ligands selective for G-quadruplex structures 43
Nucleolipidic-based liposomes effectively deliver a Ru(III) complex across cell membranes to nuclei promoting in concert apoptosis and autophagy in human models of breast cancer 40
Exploring the conformational behaviour and aggregation properties of lipid-conjugated AS1411 aptamers 40
Fine-tuning the properties of the thrombin binding aptamer through cyclization: Effect of the 5′-3′ connecting linker on the aptamer stability and anticoagulant activity 39
Disentangling the Structure-Activity Relationships of Naphthalene Diimides as Anticancer G-Quadruplex-Targeting Drugs 38
Fluorescent Thrombin Binding Aptamer-Tagged Nanoparticles for an Efficient and Reversible Control of Thrombin Activity 37
AS1411-decorated niosomes as effective nanocarriers for Ru(III)-based drugs in anticancer strategies 37
Anti-VEGF DNA-based aptamers in cancer therapeutics and diagnostics 36
Synthesis, DNA binding studies, and antiproliferative activity of novel Pt(II)-complexes with an L-alanyl-based ligand 35
G-quadruplex-based aptamers targeting human thrombin: Discovery, chemical modifications and antithrombotic effects 32
Exploring the Binding of Natural Compounds to Cancer-Related G-Quadruplex Structures: From 9,10-Dihydrophenanthrenes to Their Dimeric and Glucoside Derivatives 30
Natural compounds from Juncus plants interacting with telomeric and oncogene G-quadruplex structures as potential anticancer agents 30
Truncated Analogues of a G-Quadruplex-Forming Aptamer Targeting Mutant Huntingtin: Shorter Is Better! 29
G-Quadruplex Forming Oligonucleotides as Anti-HIV Agents 28
Self-assembly of thyminyl l-tryptophanamide (TrpT) building blocks for the potential development of drug delivery nanosystems 26
RuIII Complexes for Anticancer Therapy: The Importance of Being Nucleolipidic 26
Tuning the polymorphism of the anti-VEGF G-rich V7t1 aptamer by covalent dimeric constructs 26
Selective light-up of dimeric G-quadruplex forming aptamers for efficient VEGF165 detection 24
Insights into the Small Molecule Targeting of Biologically Relevant G-Quadruplexes: An Overview of NMR and Crystal Structures 23
Safety and efficacy evaluation in vivo of a cationic nucleolipid nanosystem for the nanodelivery of a ruthenium(III) complex with superior anticancer bioactivity 21
Charge-transfer interactions stabilize g-quadruplex-forming thrombin binding aptamers and can improve their anticoagulant activity 21
A terminal functionalization strategy reveals unusual binding abilities of anti-thrombin anticoagulant aptamers 20
Nanoparticle-guided brain drug delivery: Expanding the therapeutic approach to neurodegenerative diseases 20
Bioengineered lipophilic Ru(III) complexes as potential anticancer agents 18
Dimeric and Multimeric DNA Aptamers for Highly Effective Protein Recognition 18
Triple Negative Breast Cancer Preclinical Therapeutic Management by a Cationic Ruthenium-Based Nucleolipid Nanosystem 18
Design, synthesis and characterization of cyclic nu172 analogues: A biophysical and biological insight 17
Modular symmetric ligands for selective recognition of cancer-relevant G-quadruplexes 15
Synthesis and characterization of multifunctional nanovesicles composed of POPC lipid molecules for nuclear imaging 14
Directing in Vitro Selection towards G‐quadruplex‐forming Aptamers to Inhibit HMGB1 Pathological Activity 13
Probing naphthalene diimide and 3-hydroxypropylphosphate as end-conjugating moieties for improved thrombin binding aptamers: Structural and biological effects 13
Understanding the biological activities of vitamin d in type 1 neurofibromatosis: New insights into disease pathogenesis and therapeutic design 11
Investigating the Interaction of an Anticancer Nucleolipidic Ru(III) Complex with Human Serum Proteins: A Spectroscopic Study 10
Design, Synthesis, and Characterization of an Amphiphilic Lipoic Acid-Based Ru(III) Complex as a Versatile Tool for the Functionalization of Different Nanosystems 9
Metal-Based Complexes in Cancer 9
Nucleic acid-based aptamers in therapeutics and diagnostics 6
Totale 1.826
Categoria #
all - tutte 8.567
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.567


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020113 0 0 0 0 23 4 10 8 27 16 21 4
2020/2021134 3 1 3 11 16 12 4 2 23 16 1 42
2021/2022234 0 0 1 7 5 7 7 10 37 10 66 84
2022/2023471 45 51 8 31 52 51 14 51 68 47 37 16
2023/2024334 11 68 43 27 17 26 24 34 4 0 45 35
2024/2025247 75 98 14 33 27 0 0 0 0 0 0 0
Totale 1.826